<DOC>
	<DOCNO>NCT01417923</DOCNO>
	<brief_summary>Vitamin D3 produce skin following exposure UVB light sun artificial source , occur naturally small range foods.More recently , several report underline impact vitamin D prevalence consequence inadequate vitamin D intake research support benefit alleviate chronic musculoskeletal pain fatigue syndromes outpatient . Experts recommend vitamin D inadequacy address patient bone joint pain , myalgia , fibromyalgia , chronic fatigue syndrome . It appear soothe daily musculoskeletal pain supplementation vitamin D may simple , well tolerate , cost-effective modality . Aim study : To study potential therapeutic effect vitamin D supplementation patient persistent musculo-skeletal pain . Clinicalparameters , visual analog score , short form McGill Pain Questionnaire , patient global perceived effect , quality life assess SF-36 Questionnaire laboratory parameter , level 25 OH-Vitamin D , CRP , IL-6 , IL-8 , TNF prostaglandin E assess .</brief_summary>
	<brief_title>The Immune Clinical Impacts Vitamin D Patients With Chronic Musculo-skeletal Pain</brief_title>
	<detailed_description>The immune clinical impact vitamin D patient chronic musculo-skeletal pain Background Vitamin D group fat-soluble secosteroids , two major physiologically relevant form vitamin D2 ( ergocalciferol ) vitamin D3 ( cholecalciferol ) . Vitamin D without subscript refers either D2 D3 . Vitamin D3 produce skin following exposure UVB light sun artificial source , occur naturally small range food . Vitamin D carry bloodstream liver , convert prohormone calcidiol . Circulating calcidiol may convert calcitriol , biologically active form vitamin D , either kidneys monocyte-macrophages immune system . When synthesized monocyte-macrophages , calcitriol act locally cytokine , defend body microbial invader ( 1 ) . When synthesized kidney , calcitriol circulates hormone , regulate among thing , concentration calcium phosphate bloodstream , promote healthy mineralization , growth remodel bone , also vital normal function different arm immune system ( 1 ; 2 ) . Vitamin D receptor activation intestine , bone , kidney , parathyroid gland cell lead maintenance calcium phosphorus level blood ( assistance parathyroid hormone calcitonin ) maintenance bone content . Vitamin D increase expression tyrosine hydroxylase gene adrenal medullary cell . Vitamin D involve biosynthesis neurotrophic factor , synthesis nitric oxide synthase , increase glutathione level . Adequate vitamin D may also associate healthy hair follicle growth cycle ( 3 ) . Vitamin D insufficiency result thin brittle bone , whereas sufficiency prevents rickets child osteomalacia adult help protect elderly osteoporosis . Vitamin D also direct muscle strength function ( 4 ; 5 ) . Nevertheless , persuasive evidence lower vitamin D status chronic pain sufferer . There also association low 25 ( OH ) D level peripheral vascular disease ( 6 ) , certain cancer ( 7-10 ) , multiple sclerosis ( 11 ) , rheumatoid arthritis ( 12-15 ) , juvenile diabetes ( 16-18 ) , Parkinson 's Alzheimer 's disease ( 19 ; 20 ) . However association find observational study vitamin D vitamin supplement demonstrate reduce risk disease . More recently , several report underline impact vitamin D prevalence consequence inadequate vitamin D intake research support benefit alleviate chronic musculoskeletal pain fatigue syndromes outpatient . There extensive report pain worldwide much chronic , last 3 month , primarily involve muscle , bone joint . In United States , half adult participate survey report long term persistent intermittent pain , low upper back , neck , shoulder , hip , knee mention frequently ( 21 ) . For lower-back pain alone , annual incidence 50 % lifetime prevalence 80 % report ( 22 ) . In 8 10 case , cause nonspecific , without evidence injury , disease , anatomical defect ( 23 ; 24 ) . More quarter ( 28 % ) patient chronic pain rate effectiveness medical treatment poor , ( 77 % ) believe new option need treat pain ( 25-27 ) . It appear soothe daily musculoskeletal pain supplementation vitamin D may simple , well tolerate , cost-effective modality . Experts recommend vitamin D inadequacy address patient bone joint pain , myalgia , fibromyalgia , chronic fatigue syndrome ( 28 ; 29 ) . However , seem unknown overlook many healthcare provider . Research vitamin D still emerge field , divergent opinion among expert regard many aspect vitamin D pharmacology , function , adequate intake need good health . While research need , clinical evidence date recommend vitamin D supplementation musculoskeletal pain associate symptom seem grow . In 3670 patient take part different study musculoskeletal pain significant vitamin D inadequacies find 48 % 100 % . A study Mayo Clinic report whop 93 % patient `` chronic nonspecific pain syndrome '' deficient level vitamin D ( 30 ) . When supplementation provide improve vitamin D status , pain and/or muscle weakness resolve least subsided case , associated improvement physical functioning . A recently report prospective study 51 patient type 2 diabetes associate chronic , painful neuropathy find conservative vitamin D supplementation ( 2000 IU/day ) 3 month result nearly 50 % decrease pain score , symptom improve `` distress '' `` mild '' average ( 31 ) . There early case report patient type 1 diabetes whose severe neuropathy confine wheelchair . This patient 's ache pain resolve high-dose vitamin D supplementation , reportedly able walk unassisted within 4 week ( 32 ) . Other therapy need discontinue trial vitamin D `` analgesia . Miller et al ( 33 ) evaluate cohort Baltimore Hip Studies , woman age &gt; 65 year baseline 2 , 6 , 12 month hip fracture repair . Serum baseline analyze 25-hydroxyvitamin D [ 25 ( OH ) D ] serum time point analyze IL-6 , woman vitamin D deficiency time hip fracture high serum IL-6 level year hip fracture . Aim study To study potential therapeutic effect vitamin D supplementation patient persistent musculo-skeletal pain . Clinical laboratory parameter assess . Methods We enrol 80 patient age 18-80 year suffer chronic musculo-skeletal pain ( low back pain , fibromyalgia , chronic widespread pain ) least 6 month . The enrollee randomize double-blinded manner two follow group : Group 1 receive daily dos 4000 unit vitamin D ( 4 drop 1,000 ) Group 2 receive placebo . Written inform consent obtain participate patient . On day recruitment blood drawn order determine level 25 OH-Vitamin D , CRP , IL-6 , IL-8 , TNF prostaglandin E2 . Vitamin D placebo take 6 week top individual 's daily medication . A second blood analysis conduct follow 6 week duration . Additional outcome measure pain intensity assess visual analog score ( VAS ) ( 0 = pain , 10 = worst imaginable pain ) , short form McGill Pain Questionnaire ( SMPQ ) , patient global perceive effect ( PGPE ) , score patient 7-point Likert scale ( bad good ) , quality life assess SF-36 Questionnaire evaluate base line , 6 week , 12 week 6 month inclusion . At 12 week period third 25 OH-Vitamin D blood level measure . Rescue medication provide paracetamol 325mg+codein 15 mg . Consumption pain medication record study 2 week interval . Adverse event record 6 week period patient report . The vitamin D level assess use commercial kit , LIAISONÂ® 25-OH vitamin D Assay ( 310900 ) ( Cardinal Health , Inc. , Dublin , OH , USA ) . The method quantitative determination 25-OH vitamin D direct , competitive chemiluminescence immunoassay . The assay assess ELISA kit . Statistics perform use SPSS 18th edition use Student 's t-test Chi-Square test appropriate Fisher 's exact test . To adjust difference baseline value , analysis perform use multivariate logistic regression model . Consumption medication compare use Man-Whitney U test . Significance regard p value low 0.05 .</detailed_description>
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Musculoskeletal Pain</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<criteria>We enrol patient suffer chronic musculoskeletal pain ( low back pain , fibromyalgia , chronic widespread pain ) least 6 month . Patients low compliance Allergy vit D</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>chronic musculo-skeletal pain</keyword>
	<keyword>therapeutic &amp; serology effect vitamin D</keyword>
	<keyword>CRP , IL-6 , IL-8 , TNF prostaglandin E2</keyword>
	<keyword>patient suffer chronic musculo-skeletal pain</keyword>
</DOC>